1. Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study 
M Wąsowicz, S Syed, D.N. Wijeysundera, Ł Starzyk, D Grewal, T Ragoonanan, P Harsha, G Travis, J Carroll, K Karkouti, W.S. Beattie 
British Journal of Anaesthesia 
Volume 116, Issue 4, Pages (April 2016)
DOI: /bja/aev556
Copyright © 2016 The Author(s) Terms and Conditions

2. Fig 1
Onset of troponin elevation in subjects experiencing a major adverse cardiac event. Each bar represents the number of subjects in the time period that had a new troponin concentration greater than the 99th percentile for a normal population. Note that after day 2 (48 h), samples were drawn on the morning of the third, fourth, and fifth postoperative day. Twenty-one subjects had signs of myocardial infarction within 24 h of surgery.
British Journal of Anaesthesia  , DOI: ( /bja/aev556)
Copyright © 2016 The Author(s) Terms and Conditions

3. Fig 2
Post hoc analysis of residual platelet inhibition after aspirin withdrawal. This box plot shows the residual platelet inhibition 7, 3–7, and <3 days without aspirin. The line in each box is the median, the diamond is the mean, the upper and lower bars of the box represent the 25th and 75th percentiles, and the central whisper line represents the range of values seen.
British Journal of Anaesthesia  , DOI: ( /bja/aev556)
Copyright © 2016 The Author(s) Terms and Conditions